3PJD image
Entry Detail
PDB ID:
3PJD
Title:
Structure of ENR G93A mutant-NAD+-Triclosan complex
Biological Source:
Source Organism:
Host Organism:
PDB Version:
Deposition Date:
2010-11-10
Release Date:
2011-04-20
Method Details:
Experimental Method:
Resolution:
2.50 Å
R-Value Free:
0.23
R-Value Work:
0.21
R-Value Observed:
0.21
Space Group:
P 61 2 2
Macromolecular Entities
Polymer Type:polypeptide(L)
Description:Enoyl-[acyl-carrier-protein] reductase [NADH]
Mutations:G93A
Chain IDs:A, B
Chain Length:270
Number of Molecules:2
Biological Source:Escherichia coli
Primary Citation
Structural basis of triclosan resistance
J.Struct.Biol. 174 173 179 (2011)
PMID: 21094257 DOI: 10.1016/j.jsb.2010.11.008

Abstact

Triclosan (5-chloro-2-(2,4-dichloro-phenoxy)-phenol, TCL) is a well known inhibitor against enoyl-acyl carrier protein reductase (ENR), an enzyme critical for cell-wall synthesis of bacteria. The inhibitory concentration at 50% inhibition (IC(50)) of TCL against the Escherichia coli ENR is 150nM for wild type (WT), 380, 470 and 68,500nM for Ala, Ser and Val mutants, respectively. To understand this high TCL resistance in the G93V mutant, we obtained the crystal structures of mutated ENRs complexed with TCL and NAD(+). The X-ray structural analysis along with the ab initio calculations and molecular dynamics simulations explains the serious consequence in the G93V mutant complex. The major interactions around TCL due to the aromatic(cation)-aromatic and hydrogen bonding interactions are found to be conserved both in WT and mutant complexes. Thus, the overall structural change of protein is minimal except that a flexible α-helical turn around TCL is slightly pushed away due to the presence of the bulky valine group. However, TCL shows substantial edge-to-face aromatic (π)-interactions with both the flexible R192-F203 region and the residues in the close vicinity of G93. The weakening of some edge-to-face aromatic interactions around TCL in the G93V mutant results in serious resistance to TCL. This understanding is beneficial to design new generation of antibiotics which will effectively act on the mutant ENRs.

Legend

Protein

Chemical

Disease

Primary Citation of related structures